Hypoxia-Pretreated Human MSCs Attenuate Acute Kidney Injury through Enhanced Angiogenic and Antioxidative Capacities

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Zhang, Wenbo ^a   Liu, Lirui ^a   Huo, Yanhong ^a   Yang, Yonghong ^a   Wang, Yaping ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; CREATININE; HYDROETHIDINE; PHOSPHATE BUFFERED SALINE; ANTIOXIDANT;

ACUTE KIDNEY FAILURE; ADIPOSE TISSUE; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL HYPOXIA; CONTROLLED STUDY; CREATININE BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; KIDNEY CELL; KIDNEY FUNCTION; KIDNEY PARENCHYMA; MALE; MESENCHYMAL STEM CELL; NONHUMAN; PARACRINE SIGNALING; RAT; UREA NITROGEN BLOOD LEVEL; VASCULARIZATION; ACUTE KIDNEY INJURY; ANIMAL; CELL SEPARATION; CYTOLOGY; KIDNEY; KIDNEY FUNCTION TEST; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; OXIDATION REDUCTION REACTION; PATHOLOGY; PATHOPHYSIOLOGY; REPERFUSION INJURY; SPRAGUE DAWLEY RAT;

RATTUS;

ACUTE KIDNEY INJURY; ADIPOSE TISSUE; ANIMALS; ANTIOXIDANTS; APOPTOSIS; BLOOD UREA NITROGEN; CELL HYPOXIA; CELL SEPARATION; CREATININE; HUMANS; KIDNEY; KIDNEY FUNCTION TESTS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; NEOVASCULARIZATION, PHYSIOLOGIC; OXIDATION-REDUCTION; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY;

EID: 84923418455     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/462472     Document Type: Article

References (33)

1. N. Lameire, W. van Biesen, and R. Vanholder, "Acute renal failure, " The Lancet, vol. 365, no. 9457, pp. 417-430, 2005.
2. J. Gao, R. Liu, J. Wu, et al., "The use of chitosan based hydrogel for enhancing the therapeutic benefits of adipose-derived MSCs for acute kidney injury, " Biomaterials, vol. 33, no. 14, pp. 3673-3681, 2012.
3. J. V. Bonventre and J. M. Weinberg, "Recent advances in the pathophysiology of ischemic acute renal failure, " Journal of the American Society of Nephrology, vol. 14, no. 8, pp. 2199-2210, 2003.
4. P. Liu, Y. Feng, C. Dong, et al., "Study on therapeutic action of bone marrow derived mesenchymal stem cell combined with vitamin e against acute kidney injury in rats, " Life Sciences, vol. 92, no. 14-16, pp. 829-837, 2013.
5. N. Lameire, W. Van Biesen, and R. Vanholder, "The changing epidemiology of acute renal failure, " Nature Clinical Practice Nephrology, vol. 2, no. 7, pp. 364-377, 2006.
6. S. Hagiwara, H. Koga, H. Iwasaka, et al., "ETS-GS, a new antioxidant, ameliorates renal ischemia-reperfusion injury in a rodent model, " Journal of Surgical Research, vol. 171, no. 1, pp. 226-233, 2011.
7. R. Rodrigoand C. Bosco, "Oxidative stress and protective effects of polyphenols: comparative studies in human and rodent kidney. A review, " Comparative Biochemistry and Physiology-C Toxicology and Pharmacology, vol. 142, no. 3-4, pp. 317-327, 2006.
8. E. Noiri, A. Nakao, K. Uchida, et al., "Oxidative and nitrosative stress in acute renal ischemia, " The American Journal of Physiology: Renal Physiology, vol. 281, no. 5, pp. F948-F957, 2001.
9. P. Devarajan, "Update onmechanisms of ischemic acute kidney injury, " Journal of theAmericanSociety of Nephrology, vol. 17, no. 6, pp. 1503-1520, 2006.
10. W. Zhuo, L. Liao, T. Xu, W. Wu, S. Yang, and J. Tan, "Mesenchymal stem cells ameliorate ischemia-reperfusion-induced renal dysfunction by improving the antioxidant/oxidant balance in the ischemic kidney, " Urologia Internationalis, vol. 86, no. 2, pp. 191-196, 2011.
11. M. P. Castaneda, A. Swiatecka-Urban, M. M. Mitsnefes, et al., "Activation of mitochondrial apoptotic pathways in human renal allografts after ischemia-reperfusion injury, " Transplantation, vol. 76, no. 1, pp. 50-54, 2003.
12. Y. Chen, C. Sun, Y. Lin, et al., "Adipose-derived mesenchymal stem cell protects kidneys against ischemia-reperfusion injury through suppressing oxidative stress and inflammatory reaction, " Journal of Translational Medicine, vol. 9, article 51, 2011.
13. K. Rubina, N. Kalinina, A. Efimenko, et al., "Adipose stromal cells stimulate angiogenesis via promoting progenitor cell differentiation, secretion of angiogenic factors, and enhancing vesselmaturation, " Tissue Engineering A, vol. 15, no. 8, pp. 2039-2050, 2009.
14. S. Fatma, D. E. Selby, R. D. Singla, and D. K. Singla, "Factors released from embryonic stem cells stimulate c-kit-FLK-1 +ve progenitor cells and enhance neovascularization, " Antioxidants and Redox Signaling, vol. 13, no. 12, pp. 1857-1865, 2010.
15. J. M. Gimble, A. J. Katz, and B. A. Bunnell, "Adipose-derived stem cells for regenerative medicine, " Circulation Research, vol. 100, no. 9, pp. 1249-1260, 2007.
16. P. A. Zuk, M. Zhu, P. Ashjian, et al., "Human adipose tissue is a source of multipotent stem cells, " Molecular Biology of the Cell, vol. 13, no. 12, pp. 4279-4295, 2002.
17. M. Ren, W. Peng, Z. Yang, et al., "Allogeneic adipose-derived stem cells with low immunogenicity constructing tissueengineered bone for repairing bone defects in pigs, " Cell Transplantation, vol. 21, no. 12, pp. 2711-2721, 2012.
18. F. Verseijden, H. Jahr, S. J. Posthumus-van Sluijs, et al., "Angiogenic capacity of human adipose-derived stromal cells during adipogenic differentiation: an in vitro study, " Tissue Engineering A, vol. 15, no. 2, pp. 445-452, 2009.
19. T. J. Bartosh, J. H. Ylostalo, A. Mohammadipoor, et al., "Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties, " Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 31, pp. 13724-13729, 2010.
20. X. Hu, S. P. Yu, J. L. Fraser, et al., "Transplantation of hypoxiapreconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis, " Journal of Thoracic and Cardiovascular Surgery, vol. 135, no. 4, pp. 799-808, 2008.
21. W. Li, N. Ma, L. Ong, et al., "Bcl-2 engineered MSCs inhibited apoptosis and improved heart function, " Stem Cells, vol. 25, no. 8, pp. 2118-2127, 2007.
22. L. Liu, J. Gao, Y. Yuan, Q. Chang, Y. Liao, and F. Lu, "Hypoxia preconditioned human adipose derived mesenchymal stem cells enhance angiogenic potential via secretion of increased VEGF and bFGF, " Cell Biology International, vol. 37, no. 6, pp. 551-560, 2013.
23. B. Park, W. Kim, J. Choi, et al., "Hair growth stimulated by conditioned medium of adipose-derived stem cells is enhanced by hypoxia: evidence of increased growth factor secretion, " Biomedical Research, vol. 31, no. 1, pp. 27-34, 2010.
24. S. H. Kim, H. Moon, H. A. Kim, K. Hwang, M. Lee, and D. Choi, "Hypoxia-inducible vascular endothelial growth factor-engineered mesenchymal stem cells prevent myocardial ischemic injury, " MolecularTherapy, vol. 19, no. 4, pp. 741-750, 2011.
25. L. Wei, J. L. Fraser, Z. Lu, X. Hu, and S. P. Yu, "Transplantation of hypoxia preconditioned bone marrow mesenchymal stem cells enhances angiogenesis and neurogenesis after cerebral ischemia in rats, " Neurobiology of Disease, vol. 46, no. 3, pp. 635-645, 2012.
26. Z. Liu, H. Wang, Y. Wang, et al., "The influence of chitosan hydrogel on stem cell engraftment, survival and homing in the ischemic myocardial microenvironment, " Biomaterials, vol. 33, no. 11, pp. 3093-3106, 2012.
27. M. Savas, E. Yeni, H. Ciftci, et al., "The antioxidant role of oral administration of garlic oil on renal ischemiareperfusion injury, " Renal Failure, vol. 32, no. 3, pp. 362-367, 2010.
28. A. Sivarajah, P. K. Chatterjee, N. S. A. Patel, et al., "Agonists of peroxisome-proliferator activated receptor-gamma reduce renal ischemia/reperfusion injury, " The American Journal of Nephrology, vol. 23, no. 4, pp. 267-276, 2003.
29. M. Gnecchi, H. He, O. D. Liang, et al., "Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells, " Nature Medicine, vol. 11, no. 4, pp. 367-368, 2005.
30. S. Ling, R. Wang, Z. Q. Dai, et al., "Pretreatment of rat bone marrow mesenchymal stem cells with a combination of hypergravity and 5-azacytidine enhances therapeutic efficacy for myocardial infarction, " Biotechnology Progress, vol. 27, no. 2, pp. 473-482, 2011.
31. Y. Miyahara, N. Nagaya, M. Kataoka, et al., "Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction, " Nature Medicine, vol. 12, no. 4, pp. 459-465, 2006.
32. P. Hao, Z. Liang, H. Piao, et al., "Conditioned medium of human adipose-derivedmesenchymal stem cellsmediates protection in neurons following glutamate excitotoxicity by regulating energy metabolism and GAP-43 expression, " Metabolic Brain Disease, vol. 29, no. 1, pp. 193-205, 2014.
33. L. Chen, Y. Xu, J. Zhao, et al., "Conditioned medium from hypoxic bone marrow-derived mesenchymal stem cells enhances wound healing in mice, " PLoS ONE, vol. 9, no. 4, Article ID e96161, 2014.